Orifarm

Last updated
Orifarm
Formation1994
FounderBrigitte and Hans Bøgh-Sørensen
HeadquartersOdense, Denmark
Subsidiaries Pilatus Comparator Solutions
Website https://www.orifarm.com/

Orifarm (founded 1994) is a Danish pharmaceutical company [1] [2] based in Odense. [3] [4] [5]

Contents

History

Orifarm is a family-owned company established in 1994 by Hans Bøgh-Sørensen and his wife Birgitte Bøgh-Sørensen. [6] [7]

Orifarm entered the market in 1995 with a portfolio of 25 products and 9 employees. Since then, the company has experienced significant growth and currently employs approximately 2,200 colleagues across multiple locations in Europe and the United States. [8]

In 1997, Orifarm expanded into Sweden, marking its first presence in a European market beyond Denmark. By 2014, Orifarm entered the Dutch market, establishing its sixth sales office in Europe. [9] [10]

In 2019, Orifarm extended its operations beyond Europe by acquiring Pilatus Comparator Solutions, a company active in the United Kingdom, Germany, and the United States. [11]

In 2020, the company bought a part of Takeda Pharmaceutical Company (Japan) and the [3] [12] [13] rights to a number of over-the-counter and prescription medicines for DKK 4.6 billion (670 USD). [14] [15] Through this acquisition, Orifarm also gained control of two production facilities in Łyszkowice, Poland, and Hobro, Denmark. [16]

2021 marked significant progress for Orifarm. The company’s revenue increased by 27%, equivalent to EUR 10,54 billion Danish kroner (EUR 1,417 billion) . Operating profit also rose by 39%, reaching 413 million Danish kroner (EUR 55,3 million). [17]

Related Research Articles

<span class="mw-page-title-main">Over-the-counter drug</span> Medication available without a prescription

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) and strengths of final products.

<span class="mw-page-title-main">Takeda Pharmaceutical Company</span> Japanese pharmaceutical company

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that is permitted to be dispensed only to those with a medical prescription. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

<span class="mw-page-title-main">Swan Lee</span> Danish band

Swan Lee is a Danish indie rock band consisting of singer Pernille Rosendahl, guitarist Jonas Struck and drummer Emil Jørgensen. Swan Lee has released three albums on their own label GoGo Records: Enter (2001), Swan Lee (2004) and The Garden (2023). They have won Danmarks Radio's P3 award, and are particularly known for the singles "Tomorrow Never Dies", "Love Will Keep You Warm" and "I Don't Mind".

Frederik Lauesen is a Danish TV presenter, who has been head of sport for the Danish channel TV 2 since September 2008.

<span class="mw-page-title-main">UCB (company)</span> Biopharmaceutical company

UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system (CNS) disorders, inflammatory disorders, and oncology.

Takeda Oncology is a biopharmaceutical company based in Cambridge, Massachusetts. It is a fully owned subsidiary of Takeda Pharmaceutical.

<span class="mw-page-title-main">Zentiva</span> Czech pharmaceutical company

Zentiva is a pharmaceutical company based in Prague, Czech Republic. The company is developing, manufacturing and marketing a wide range of generic and OTC products.

Stig Kristensen, is a Danish cartoonist and illustrator, and author of the Danish comic strip "Stig's Stribe" which currently is published in the Danish newspaper, Fyens Stiftstidende. Stig's Stribe has appeared on the paper's back page since November 2007.

<span class="mw-page-title-main">Middelfart Boldklub</span> Association football club in Middelfart, Denmark

Middelfart Boldklub is a Danish football club which plays in the Danish 2nd Division, the third tier of Danish football. They play at Middelfart Stadion in Middelfart, which has a capacity of 4,100.

Niels Thorborg is the chairman of the Danish football club Odense Boldklub. He is also the former richest person on Funen with a fortune of 3.1 billion Danish kroner.

The Danish Defence Acquisition and Logistics Organization (DALO) is a joint service unit under the Ministry of Defence, tasked with purchase, service and support of equipment within the Danish Defence. It used to be known as the Danish Defence Material Service.

<span class="mw-page-title-main">Leo Pharma</span> Danish pharmaceutical company

LEO Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries. Its headquarters are in Ballerup, near Copenhagen The company is 100% integrated into a private foundation owned by the LEO Foundation. LEO Pharma develops and markets products for dermatology, bone remodeling thrombosis and coagulation. In 1945, it was the first producer of penicillin outside the US and UK.

<span class="mw-page-title-main">Vianex S.A.</span> Greek pharmaceutical company

Vianex S.A. is a Greek pharmaceutical company, founded in 1971 by the Giannakopoulos’ family that has been involved with the pharmaceutical industry since 1924.

<span class="mw-page-title-main">Novo Holdings A/S</span> Danish holding company

Novo Holdings A/S is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2023 was worth almost DKK 1,114 billion Danish Kroner. The company generated a total income and investment return of DKK 31 billion in 2023.

Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.

<span class="mw-page-title-main">2015 Danish European Union opt-out referendum</span>

A referendum on one of the country's opt-outs from the European Union was held in Denmark on 3 December 2015. Specifically, the referendum was on whether to convert Denmark's current full opt-out on home and justice matters into an opt-out with case-by-case opt-in similar to those held by Ireland and the United Kingdom. Approval of the referendum was needed for Denmark to remain in Europol under the new rules. However, it was rejected by 53% of voters.

<span class="mw-page-title-main">Viking Link</span> Submarine power cable between the UK and Denmark

Viking Link is a 1,400 MW HVDC submarine power cable between the United Kingdom and Denmark, which was completed in 2023. As of 2024, it is the longest land and subsea HVDC interconnector in the world. The project is a cooperation between British National Grid and Danish Energinet.

Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley.

Cane-line is a Danish furniture company based in Rynkeby (Odense), Denmark. It is a producer and manufacturer of indoor and outdoor furniture and accessories

References

  1. "101 Top Health Care Startups and Companies in Denmark (2021)".
  2. "PIL error: Orifarm Concerta XL | Dispensing Doctor Association". www.dispensingdoctor.org. Retrieved 2024-03-26.
  3. 1 2 Tirumalaraju, Divya (2020-04-24). "Takeda to sell OTC and non-core assets to Orifarm for $670m". Pharmaceutical Technology. Retrieved 2024-03-26.
  4. "Information management platform startup M-Files raises $80M". SiliconANGLE. 2021-01-12. Retrieved 2024-03-26.
  5. "Takeda Sells OTC Drugs to Denmark's Orifarm | CHEManager". www.chemanager-online.com. Retrieved 2024-03-26.
  6. "The year our onboarding reached new heights - Orifarm". www.orifarm.com. Retrieved 2024-03-26.
  7. "How an acquisition helped Orifarm prepare a prescription for growth". www.ey.com. Retrieved 2024-03-26.
  8. "Orifarm ansætter flere og bygger nyt: Milliard-opkøb af japansk gigant var en større mundfuld end ventet | fyens.dk". fyens.dk (in Danish). 2022-04-19. Retrieved 2024-07-01.
  9. "How an acquisition helped Orifarm prepare a prescription for growth". www.ey.com. Retrieved 2024-03-26.
  10. "Ny direktør bestod: Fynske Orifarm har aldrig tjent mere | fyens.dk". fyens.dk (in Danish). 2019-05-29. Retrieved 2024-03-26.
  11. "Orifarm has high hopes for new business arm - may be the key to the US market". medwatch.dk (in Danish). 2020-03-25. Retrieved 2024-07-01.
  12. Nawrat, Allie (2020-04-28). "Takeda-Orifarm deal: another divestiture for the Japanese pharma giant". Pharmaceutical Technology. Retrieved 2024-03-26.
  13. Wessel, Lene (2022-06-10). "HR-direktør om onboarding af 900 medarbejdere: "Hold øje med de bløde ting" | PeopleTech (PRO)". ing.dk (in Danish). Retrieved 2024-03-26.
  14. "Konkurrencerådet griber ind i Orifarms overtagelse af dele af Takeda". www.kfst.dk (in Danish). 2021-03-24. Retrieved 2024-03-26.
  15. "Large multimillion Euro acquisition - Orifarm". www.orifarm.com. Retrieved 2024-03-26.
  16. "Orifarm køber lægemidler og fabrikker af Takeda for 4,6 mia. kr". medwatch.dk (in Danish). 2020-04-24. Retrieved 2024-07-01.
  17. "Orifarm i stor fremgang - omsætningen runder 10 mia. kr". medwatch.dk (in Danish). 2022-07-04. Retrieved 2024-07-01.

Commons-logo.svg Media related to Orifarm at Wikimedia Commons